Inhibition of platelet function by administration of MRS2179, a P2Y 1 receptor antagonist

By Baurand A.   Raboisson P.   Freund M.   Leon C.   Cazenave J.-P.   Bourguignon J.-J.   Gachet C.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Evidence for a G protein-coupled diadenosine-5',5&unknown;-P 1 ,P 4 -tetraphosphate (Ap 4 A) receptor binding site in lung membranes from rat

By Laubinger W.   Reiser G.  

European Journal of Pharmacology, Vol. 366, Iss. 1, 1999-01 ,pp. : 93-100

Elsevier

Access to resources Recommend Favorite

Structure-Activity Relationships of Suramin and Pyridoxal-5'-phosphate Derivatives as P2 Receptor Antagonists

By  

Current Pharmaceutical Design, Vol. 8, Iss. 26, 2002-12 ,pp. : 2371-2399

Bentham Science Publishers

Access to resources Recommend Favorite

On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues

By Bultmann R.   Tuluc F.   Starke K.  

European Journal of Pharmacology, Vol. 351, Iss. 2, 1998-06 ,pp. : 209-215

Elsevier

Access to resources Recommend Favorite

Selectivity of diadenosine polyphosphates for rat P2X receptor subunits

By Wildman S.S.   Brown S.G.   King B.F.   Burnstock G.  

European Journal of Pharmacology, Vol. 367, Iss. 1, 1999-02 ,pp. : 119-123

Elsevier

Access to resources Recommend Favorite